Clinical researchers are constantly plagued with data problems. They are required to utilize data from chemical compounds, genome sequencing, and drug trials to formulate the optimal drug treatments for certain diseases.
During this webinar, Prinicipal Data Scientist Johan Grahnen demonstrates how pharmaceutical companies are enriching their research and development process with Ayasdi Cure. Johan highlights the Ayasdi Cure features that help clinical researchers discover biomarkers, detect adverse effects of drugs, and discover new drug targets.
Johan holds a Ph.D. in Computational Biology from the University of Wyoming. Before coming to Ayasdi, he was a post-doctoral researcher at Georgia Institute of Technology, where he worked in metabolomics and systems biology. When not in the office, he can be found clinging to the sheer rock faces of the Sierra Nevada mountains.